Amryt posts €1.35m sales as pipeline drugs advanced
Company formed last year through reverse takeover of former oil and gas firm Fastnet
Amryt Pharmaceutical records €4.1m first-half loss
Company also announces granting of US patent for its lead drug Episalvan
Amryt reports €2.5m loss for nine months
Orphan drug development business was subject to reverse takeover by oil and gas group Fastnet
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices